๐ What is BPH?
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that compresses the urethra, causing lower urinary tract symptoms (LUTS). It affects over 50% of men over 60 and 90% over 85, making it one of the most common conditions in ageing men.
๐ฏ Symptoms
- Nocturia โ waking 2 or more times per night to urinate
- Weak or intermittent urine stream โ reduced flow, straining
- Urgency โ sudden, difficult-to-defer urge to urinate
- Frequency โ urinating more than every 2 hours during the day
- Incomplete emptying โ sensation of residual urine
- Post-void dribbling โ leakage after urination
๐ง Treatment options
๐ Medications (first line)
Alpha-blockers (tamsulosin, alfuzosin) relax the bladder neck. 5ฮฑ-reductase inhibitors (finasteride, dutasteride) shrink the prostate. Effective for mild-moderate symptoms but require lifelong use.
๐ฉธ Prostate artery embolization (PAE)
Minimally invasive alternative to surgery. Local anaesthesia. Outpatient. Ejaculation preserved. 80โ85% IPSS improvement. Covered by French health insurance.
๐ฅ TURP (surgical gold standard)
Transurethral resection of the prostate. Highly effective (90โ95% IPSS improvement) but requires general anaesthesia, hospitalisation, and causes retrograde ejaculation in 60โ90%.
๐ IPSS score
International Prostate Symptom Score โ rates symptom severity on a scale of 0โ35. Score โฅ8 indicates treatment consideration. Calculate your IPSS โ
โ Frequently asked questions
๐ Related pages
๐ซ๐ท French version: hyperplasie-benigne-prostate.html
โ Why this page is trustworthy
Written by the Interventional Radiology team at Cochin Hospital AP-HP, Universitรฉ Paris Citรฉ. Medically reviewed by an interventional radiologist of the department. Last updated: August 2026.
๐ฅ Le service ๐ฐ Actualitรฉs ๐ฌ Recherche & essais cliniques
